A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to examine how the immune system in humans works to prevent infections and disease. This research is focused on understanding inflammatory disease that affects millions of Americans in diseases including asthma, autoimmune disease, and infection with pathogens.
The purpose of this study is to help us better understand addiction and the risk for developing alcoholism and to help us understand how the brain makes choices about drinking alcohol.
What is the purpose of this study?This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent …
The purpose of this registry is to assist CfN researchers in contacting individuals who are interested in participating in any new or ongoing studies being conducted.
The purpose of this study is to obtain information from individuals and their families with heterotaxy and related congenital heart defects in order to elucidate the molecular genetics of this disorder.
This is a research study about the brain's reward centers and what they might tell us about the brain's reward system and the risk for developing alcoholism.
What is the purpose of this study?This phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. …
What is the purpose of this study?This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed) or does not respond to treatment (refractory). Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, …
